Prevalence of Amyloid PET Positivity in Dementia SyndromesRik Ossenkoppele, Gaël Chételat, David J. Brooks et al.|JAMA|2015Cited by 668
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyJulien Chapuis, Franck Hansmannel, Marc Gistelinck et al.|Molecular Psychiatry|2013Cited by 440
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsBetty M. Tijms, Pieter Jelle Visser, Johan Gobom et al.|Brain|2020Cited by 221
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R. Morgan, B. Paul Morgan, Samuel Touchard et al.|Alzheimer s & Dementia|2019Cited by 207
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer DiseaseEdmond Teng, Carlo de Lena, Mathieu Ceccaldi et al.|JAMA Neurology|2022Cited by 188